Thane Wettig
CIK: 0001815638
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYNTRA BIO, INC.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 6, 2026KYNB
KYNTRA BIO, INC.
Tax Payment(F)Direct209 shares at avg. $8.55$2K - Jun 6, 2026KYNB
KYNTRA BIO, INC.
Tax Payment(F)Direct198 shares at avg. $6.71$1K - May 14, 2026KYNB
KYNTRA BIO, INC.
Purchase(P)Direct2.8K shares at avg. $7.09$20K - Mar 6, 2026KYNB
KYNTRA BIO, INC.
Tax Payment(F)Direct277 shares at avg. $6.84$2K - Feb 3, 2026KYNB
KYNTRA BIO, INC.
Award(A)DirectStock Option (Right to Buy)
60K shares- - Dec 6, 2025FGEN
FIBROGEN INC
Tax Payment(F)Direct259 shares at avg. $8.42$2K - Nov 17, 2025FGEN
FIBROGEN INC
Purchase(P)Direct2.7K shares at avg. $9.10$25K - Nov 13, 2025FGEN
FIBROGEN INC
Purchase(P)Direct1K shares at avg. $9.18$9K - Sep 6, 2025FGEN
FIBROGEN INC
Tax Payment(F)Direct248 shares at avg. $12.10$3K - Jun 6, 2025FGEN
FIBROGEN INC
Tax Payment(F)Direct246 shares at avg. $7.83$2K - Mar 24, 2025FGEN
FIBROGEN INC
Purchase(P)Direct145K shares at avg. $0.35$51K - Mar 6, 2025FGEN
FIBROGEN INC
Tax Payment(F)Direct367 shares at avg. $0.39$143.13 - Mar 6, 2025FGEN
FIBROGEN INC
Award(A)Direct781 shares- - Mar 6, 2025FGEN
FIBROGEN INC
Tax Payment(F)Direct22K shares at avg. $0.39$9K - Jan 9, 2025FGEN
FIBROGEN INC
Award(A)DirectStock Option (Right to Buy)
1.3M shares- - Dec 6, 2024FGEN
FIBROGEN INC
Tax Payment(F)Direct2.4K shares at avg. $0.34$808.382 - Sep 6, 2024FGEN
FIBROGEN INC
Tax Payment(F)Direct2.4K shares at avg. $0.39$921.57
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 6, 2026 | KYNB KYNTRA BIO, INC. | Tax Payment(F) | 209 | $8.55 | $1,787 | Direct |
| Jun 6, 2026 | KYNB KYNTRA BIO, INC. | Tax Payment(F) | 198 | $6.71 | $1,329 | Direct |
| May 14, 2026 | KYNB KYNTRA BIO, INC. | Purchase(P) | 2,800 | $7.09 | $19,852 | Direct |
| Mar 6, 2026 | KYNB KYNTRA BIO, INC. | Tax Payment(F) | 277 | $6.84 | $1,895 | Direct |
| Feb 3, 2026 | KYNB KYNTRA BIO, INC. | Award(A) Stock Option (Right to Buy) | 60,000 | - | - | Direct |
| Dec 6, 2025 |  FGEN FIBROGEN INC | Tax Payment(F) | 259 | $8.42 | $2,181 | Direct |
| Nov 17, 2025 | FGEN FIBROGEN INC | Purchase(P) | 2,700 | $9.10 | $24,570 | Direct |
| Nov 13, 2025 | FGEN FIBROGEN INC | Purchase(P) | 1,000 | $9.18 | $9,180 | Direct |
| Sep 6, 2025 | FGEN FIBROGEN INC | Tax Payment(F) | 248 | $12.10 | $3,001 | Direct |
| Jun 6, 2025 | FGEN FIBROGEN INC | Tax Payment(F) | 246 | $7.83 | $1,927 | Direct |
| Mar 24, 2025 | FGEN FIBROGEN INC | Purchase(P) | 145,000 | $0.35 | $50,663 | Direct |
| Mar 6, 2025 | FGEN FIBROGEN INC | Tax Payment(F) | 367 | $0.39 | $143 | Direct |
| Mar 6, 2025 | FGEN FIBROGEN INC | Award(A) | 781 | - | - | Direct |
| Mar 6, 2025 | FGEN FIBROGEN INC | Tax Payment(F) | 22,038 | $0.39 | $8,595 | Direct |
| Jan 9, 2025 | FGEN FIBROGEN INC | Award(A) Stock Option (Right to Buy) | 1,300,000 | - | - | Direct |
| Dec 6, 2024 | FGEN FIBROGEN INC | Tax Payment(F) | 2,363 | $0.34 | $808 | Direct |
| Sep 6, 2024 | FGEN FIBROGEN INC | Tax Payment(F) | 2,363 | $0.39 | $922 | Direct |
1-17 of 17 transactions
About Wettig Thane
Wettig Thane (SEC CIK 0001815638) files insider reports with the SEC as CEO of KYNTRA BIO, INC. (KYNB).
Signal8 holds 14 ownership filings by Wettig Thane, all Form 4s, filed between Sep 9, 2024 and Sep 9, 2026. Those filings report 17 transactions, from Sep 6, 2024 to Sep 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wettig Thane's filings is in SAN FRANCISCO, CA.
Recent filings by Wettig Thane
- Sep 6, 2026: Tax withholding of KYNB shares (Form 4, code F).
- Jun 6, 2026: Tax withholding of KYNB shares (Form 4, code F).
- May 14, 2026: Open-market purchase of KYNB shares (Form 4, code P).
- Mar 6, 2026: Tax withholding of KYNB shares (Form 4, code F).
- Feb 3, 2026: Grant or award of KYNB derivative securities (Form 4, code A).
Other insiders filing for KYNTRA BIO, INC. (KYNB)
- Singer Andrew E., Director
- DeLucia David, Chief Financial Officer
- Ho Maykin, Director
- EDWARDS JEFFREY L, Director
- Kauffman Michael, Director
- Schoeneck James A, Director